SASNM 2021 is a four-day Congress themed Synergy Over Singularity, Strength in Teamwork. The programme has international and local speakers sharing trends, case studies, and best practice across the categories of nuclear medicine imaging, therapy, radiotherapy and physics.
ALTERED BIODISTRIBUTION CME
This is a CME not to be missed!
Come and join Prof Freeman as he showcases some of the most common errors which may occur in Nuclear Medicine practice on a day-to-day basis. Its often the simple things that catch us out!
This session is applicable to the entire Nuclear Medicine team which may include trainees, Nuclear Physicians, radiographers, radiopharmacists and physicists alike.
Our Cardiology CME is not to be missed! For the first time in history our CME session is going to be presented as a live Multidisciplinary Team Meeting and who better to guide us through it than Professor Carlos Libhaber. Professor Libhaber, well known to SASNM members, is the only nuclear cardiologist in Africa. He will be looking at some interesting myocardial perfusion cases with local cardiologist Dr Charle Viljoen who actively participates in the Cardiology Multidisciplinary Team Meeting at Groote Schuur Hospital. We invite you to take part, and as you may have guessed, Professor Libhaber is bound to send a few questions your way.
Cardiac amyloidosis has traditionally been difficult to diagnose, uniformly progressive, and fatal. Recent advances in medical imaging and novel drug discoveries have now improved doctors’ ability to diagnose and treat this condition. Professor Olivier Gheysens, a nuclear physician from the Université catholique de Louvain (UCLouvain) will present on nuclear imaging’s role in this condition and Dr Philip Herbst will present a cardiologist’s perspective with a clinical case.
In the second half of the seminar, Shereen Bejai will offer a crucial refresher on patient preparation and imaging of patients undergoing cardiac FDG studies before Professor Gheysens returns to discuss the role of FDG PET in endocarditis and CIED infections – conditions which are notoriously difficult to manage. Please engage the speakers on these highly topical applications of nuclear cardiac imaging.
CENTRAL NERVOUS SYSTEM
Professor Jan Pruim, a nuclear physician from the University Medical Center Groningen (UMCG), will present on the role of FDOPA and FDG PET in diagnosing and distinguishing movement disorders. Professor Jonathan Carr, a neurologist with a special interest in movement disorders practicing at Tygerberg Hospital, will present clinical cases in which PET assisted. Attendees are encouraged to engage these experts in the field with questions relevant to their practice.
DOSIMETRY AND REGULATORY ASPECTS IN NUCLEAR MEDICINE
Is South Africa’s regulatory system for nuclear medicine effective in ensuring the safety of personnel, patients, and the general public? Does internal dosimetry add any real value to the treatment of patients? In this session Pieter du Toit will review some aspects of our current regulatory system. We will also work through clinical cases to prove the effectiveness of dosimetry in making radiation therapy safer and more effective.
Deciding on the appropriate isotope to use when imaging or treating patients with pheochromocytoma/paraganglioma can be extremely challenging. The biology of these tumours is hugely complex, and they all behave in their own individual way. Join Professor Rodney Hicks as he sheds some light on how nuclear medicine techniques should be used when imaging and treating these tumours. The clinical case discussion is bound to generate some interesting thoughts and concepts.
One needs to adapt one’s GFR calculations to the South African population. Dr Jen Holness will give us a practical approach. Renography is the most common paediatric nuclear medicine investigation. The world of nuclear medicine finally agrees on the procedure and interpretation of diuretic renography in children. In this session we will hear from one of the people who wrote the new EANM and SNNMI procedural guidelines for diuresis renography in infants in children, Professor Zvi Bar-Sever.
Professor Elba Etchebehere works in Brazil and has extensive experience with the imaging and treatment of patients with prostate cancer. How does someone provide the optimal imaging and care for their prostate cancer patient in a resource-limited setting?
Professor Mboyo Di Tamba Willy Vangu will share his experience with prostate cancer imaging in South Africa.
INFECTION AND INFLAMMATION
Professor Andor Glaudemans, a well-known expert in infection imaging, will introduce us to the approach and standardisation of infection and inflammation procedures in nuclear medicine. Professor Mariza Vorster will expand on the applications of the radio-isotope Gallium 68 in this realm. Professor Thomas Ebenhan will elaborate on the pre-clinical applications in infection and inflammation going forward into 2021 and beyond.
MEDICAL PHYSICS CME
Need to get a comprehensive overview of image quality and reconstruction in nuclear medicine? Let Dr Hanlie Du Raan and Professor Michael Mix take you back to basics with a focus on physics principles in SPECT. The interactive session on artifact scenarios promises to get you thinking and talking!
Ever get that sinking feeling when you are faced with interpreting a SPECT CT of the foot? Then this session is perfect for you!
Gopinath Gnanasegaran will guide you through interpretation and thereafter Graham Mc Collum our local foot orthopaedic surgeon will be going through the anatomy of the foot and share how he utilizes SPECT CT of the foot to assist with some tricky clinical dilemmas.
Missing the late-night social events from previous congresses? Be grateful we’re virtual this year because you need to be awake for this one! We will tackle those dreaded head and neck PET/CTs with Dr Tim Van Den Wyngaert from Antwerp, Belgium, while local head and neck radiologist Professor Leon Janse van Rensburg will cover some key radiological aspects.
FDG PET/CT can improve the precision of radiotherapy by providing a biological tumour volume that spares the normal tissues but incorporating it into the planning process can be complex. A strong cup of coffee will get you ready for physicist Professor Michael Mix from Freiburg, Germany who will explain how to set up a PET/CT radiotherapy planning programme and avoid potential technical pitfalls.
During the session with Dr Cristina Nanni from Bologna, Italy we will learn how FDG PET/CT is playing an increasingly important role in the management of multiple myeloma. Haematologist Dr Fatima Fazel will join Dr Celeste Burger for case presentations to illustrate this in the local setting.
Professor Marc Hendricks and Dr Stuart More will bring us up to speed on a rare paediatric disease: Langerhans cell histiocytosis. 18F FDG PET/CT is a useful tool for the staging and follow-up of this disease. A working knowledge of this disease is essential for the accurate interpretation of the images.
Our paediatric nuclear medicine technologist expert Ana Geão, the Chief NMT at the Hospital CUF Descobertas in Lisbon, will give you handy tips to ease your anxiety levels when scanning a paediatric patient.
Professor John Lazarus will discuss the added value of discussing renal scintigraphy in a multidisciplinary team. What do our colleagues really want to know?
How can we reduce the radiation we give to our young patients? Professor Frederic Fahey, a world-renowned expert in this field, will share his knowledge.
During our Pulmonary session Leonard Freeman is going to talk to us about the historical perspective and current status of VQ imaging. Prof Lionel Zuckier will be speaking to us on the controversy on how to proceed with lung scintigraphy in the time of COVID 19.
VQ imaging is a large part of Nuclear Medicine’s day to day practice and the results that we give our referring clinicians has an enormous impact on our patient’s wellbeing, particularly in the era that we are currently finding ourselves in. It is a session bound to generate much discussion, particularly on how we should approach VQ imaging in the era of COVID-19. Come and join the debate!
RADIONUCLIDE THERAPIES: PSMA LIGANDS
During our Radionuclide Therapy session we will be focussing on PSMA ligands. Professor Mike Sathekge will bring us up to speed on new developments in South Africa and Professor Rodney Hicks from the Peter MacCallum Cancer Centre in Melbourne will summarise where we currently are with PSMA ligands on the world platform.
The tumour board session is bound to generate insightful discussions and interesting debates as we bring on Professor Vikas Prasad from Ulm, Germany to join our local team of nuclear medicine and oncology specialists to discuss the management of some challenging cases in a live forum.
The Radiopharmacy session will be of interest to all professional categories in Nuclear Medicine. Prof Clemens Decristoforo from Austria will speak on Good Radiopharmacy Practice followed by Sietske Rubow highlighting ‘when things go wrong’. Janke kleynhans will then give an update on Radiopharmacy in RSA. A Q&A opportunity will round up the session.
Nuclear Medicine Technology/Radiography presentations will be integrated within the Paediatric, Infection and inflammation and Cardiology sessions. Presentations will be live-streamed or pre-recorded. All presenters will be available for the live stream during Q and A time slots at the end of each session.
The Infection and inflammation session will incorporate ‘Pearls and Pitfalls’ of WBC labelling. Common errors and correct techniques will be presented with an interactive session at the end.
In the Paediatric session Ana Geão, the Chief NMT at the Hospital Cuf Descobertas in Lisbon will present paediatric techniques and considerations. This presentation will compliment other talks in the session.
In the Cardiology session Shereen Bejai of the Cape Universities Body Imaging Centre will present PET/CT patient preparation and set-up for cardiology studies.
Call for Abstracts
The Call for Abstracts closed on 15 November 2020. Submissions have been reviewed and presenters notified.